Boston Scientific Corporation(BSX)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BSX | 68.04 B | 19.01x | 7.50% | 17.50% | $2.47 | 15.34% | 0.50 | - | $109.50 | $42.20 |
ABT | 188.25 B | 35.21x | 13.00% | 11.65% | $3.09 | 10.58% | 0.63 | 2.24% | $134.38 | $81.39 |
ISRG | 132.50 B | 42.41x | 18.50% | 28.45% | $8.72 | 17.42% | - | - | $603.88 | $328.57 |
SYK | 118.14 B | 32.59x | 9.40% | 14.43% | $9.45 | 16.51% | 0.64 | 1.06% | $392.86 | $280.25 |
EW | 51.75 B | 53.44x | 13.60% | 15.43% | $1.68 | 9.18% | 6.57 | - | $96.29 | $72.30 |
Peer Valuation & Performance Analysis
Peer group analysis for Boston Scientific Corporation (BSX) compared to its primary competitors (including ABT, ISRG, SYK) reveals distinct metrics. BSX trades at a valuation discount relative to its competitors, with a P/E ratio of 19.0x versus the peer average of 40.9x (representing a 54% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BSX's revenue growth of 7.5% lags behind the peer average of 13.6%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 17.5% is comparable to the peer average of 17.5%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BSX ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $48.58 | $49.27 | $46.80 | $46.95 | 19,720,300 | -3.36% |
| 2026-09-02 | $47.91 | $49.66 | $47.91 | $48.37 | 17,014,500 | +0.96% |
| 2026-09-01 | $49.12 | $49.12 | $47.27 | $48.08 | 12,002,100 | -2.12% |
| 2026-08-31 | $46.40 | $48.97 | $46.09 | $48.30 | 18,900,700 | +4.09% |
| 2026-08-28 | $46.85 | $47.22 | $46.50 | $46.84 | 17,145,900 | -0.02% |
| 2026-08-27 | $48.00 | $48.07 | $46.61 | $46.67 | 16,277,200 | -2.77% |
| 2026-08-26 | $47.00 | $48.54 | $46.90 | $48.17 | 36,584,800 | +2.49% |
| 2026-08-25 | $48.79 | $50.04 | $48.54 | $49.86 | 17,364,400 | +2.19% |
| 2026-08-24 | $50.29 | $50.38 | $48.77 | $49.01 | 22,024,900 | -2.55% |
| 2026-08-21 | $49.22 | $50.90 | $49.01 | $50.37 | 35,986,800 | +2.34% |
| 2026-08-20 | $51.64 | $51.80 | $49.36 | $49.37 | 20,371,400 | -4.40% |
| 2026-08-19 | $50.80 | $52.56 | $50.66 | $52.01 | 16,830,600 | +2.38% |
| 2026-08-18 | $52.38 | $52.53 | $50.45 | $50.47 | 11,719,900 | -3.65% |
| 2026-08-17 | $51.71 | $52.07 | $51.24 | $51.43 | 18,151,300 | -0.54% |
| 2026-08-14 | $52.83 | $52.99 | $51.70 | $51.83 | 16,278,700 | -1.89% |
Explore More Analysis for BSX
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.